10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2024-08-14 (Q2 2024) | Holdings: 79 | Value: $7.6B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S - ADR | 18.23% | $1.4B | +24.96% | -10.96% | |||
| PCVX - VAXCYTE INC | 8.19% | $619.5M | -56.20% | +9.29% | |||
| JANX - JANUX THERAPEUTICS INC | 5.08% | $383.9M | -39.77% | +18.61% | |||
| LEGN - LEGEND BIOTECH CORP-ADR | Add 9% ($28.6M) | 4.40% | $332.5M | -42.67% | -30.45% | ||
| RYTM - RHYTHM PHARMACEUTICALS INC | Add 14% ($31.0M) | 3.30% | $249.8M | +41.20% | +19.97% | ||
| BIIB - BIOGEN INC | Add 33% ($56.0M) | 3.01% | $227.7M | -35.73% | -21.12% | ||
| RXST - RXSIGHT INC | Add 7% ($15.2M) | 2.94% | $222.3M | -71.31% | -13.37% | ||
| RNA - AVIDITY BIOSCIENCES INC | Add 65% ($86.5M) | 2.92% | $220.6M | -19.11% | -4.14% | ||
| DYN - DYNE THERAPEUTICS INC | Add 22% ($38.6M) | 2.82% | $213.5M | -68.92% | -36.93% | ||
| ELYM - ELIEM THERAPEUTICS INC | Add 120% ($112.3M) | 2.72% | $205.8M | -79.97% | -51.37% | ||
| GERN - GERON CORP | 2.59% | $195.9M | -64.94% | -17.75% | |||
| PEPG - PEPGEN INC | 2.26% | $170.6M | -83.45% | -51.98% | |||
| TYRA - TYRA BIOSCIENCES INC | 2.20% | $166.6M | -57.55% | -35.77% | |||
| EVH - EVOLENT HEALTH INC - A | Add 48% ($53.1M) | 2.15% | $162.8M | -69.99% | -54.64% | ||
| EWTX - EDGEWISE THERAPEUTICS INC | 2.12% | $160.5M | -15.46% | +79.35% | |||
| NAMS - NEWAMSTERDAM PHARMA CO NV | Add 3% ($3.8M) | 2.05% | $154.9M | +12.84% | +44.01% | ||
| RXRX - RECURSION PHARMACEUTICALS-A | New Purchase | 1.53% | $115.4M | -29.37% | -4.56% | ||
| ETNB - 89BIO INC | Add 11% ($11.3M) | 1.50% | $113.5M | +26.88% | +1.02% | ||
| VRNA - VERONA PHARMA PLC - ADR | Add 21% ($19.0M) | 1.46% | $110.4M | +208.70% | +28.69% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | Add 1% ($852.6K) | 1.43% | $108.5M | -49.23% | -2.78% | ||
| FDMT - 4D MOLECULAR THERAPEUTICS IN | Add 1% ($980.2K) | 1.42% | $107.0M | -73.93% | -41.13% | ||
| SPRY - ARS PHARMACEUTICALS INC | 1.22% | $92.4M | +1.43% | +5.74% | |||
| WVE - WAVE LIFE SCIENCES LTD | 1.20% | $90.8M | +18.84% | +140.67% | |||
| LBPH - LONGBOARD PHARMACEUTICALS IN | 1.18% | $88.9M | +64.25% | ||||
| ACLX - ARCELLX INC | New Purchase | 1.17% | $88.5M | +5.63% | +40.04% | ||
| AXSM - AXSOME THERAPEUTICS INC | 1.06% | $80.5M | +29.06% | +8.67% | |||
| APGE - APOGEE THERAPEUTICS INC | Reduce 1% $(631.1K) | 1.02% | $77.2M | -17.25% | +3.85% | ||
| GHRS - GH RESEARCH PLC | Add 6% ($4.1M) | 1.02% | $77.0M | +27.37% | -8.18% | ||
| GPCR - STRUCTURE THERAPEUTICS INC | Add 26% ($15.2M) | 0.99% | $74.5M | -41.71% | -7.22% | ||
| LENZ - LENZ THERAPEUTICS INC | 0.96% | $72.3M | +27.58% | +39.79% | |||
| FULC - FULCRUM THERAPEUTICS INC | 0.95% | $72.0M | -22.89% | -67.41% | |||
| NKTX - NKARTA INC | 0.84% | $63.9M | -65.54% | -52.35% | |||
| DNTH - DIANTHUS THERAPEUTICS INC | 0.80% | $60.4M | -36.75% | -20.44% | |||
| MLYS - MINERALYS THERAPEUTICS INC | 0.75% | $56.8M | +67.42% | +23.04% | |||
| ITOS - ITEOS THERAPEUTICS INC | Reduce 20% $(13.4M) | 0.69% | $52.2M | -34.07% | -46.70% | ||
| URGN - UROGEN PHARMA LTD | 0.68% | $51.7M | -66.60% | -27.29% | |||
| PRAX - PRAXIS PRECISION MEDICINES I | Add 49% ($16.8M) | 0.68% | $51.1M | -20.85% | +34.41% | ||
| ELVN - ENLIVEN THERAPEUTICS INC | 0.66% | $49.6M | -5.19% | +8.30% | |||
| ACRV - ACRIVON THERAPEUTICS INC | Add 73% ($20.5M) | 0.64% | $48.4M | -82.73% | -3.87% | ||
| ATXS - ASTRIA THERAPEUTICS INC | Add 14% ($5.7M) | 0.61% | $45.9M | -48.67% | -7.87% | ||
| BCYC - BICYCLE THERAPEUTICS PLC-ADR | New Purchase | 0.60% | $45.6M | -62.29% | -3.33% | ||
| CGON - CG ONCOLOGY INC | New Purchase | 0.58% | $44.1M | -21.68% | -3.25% | ||
| LRMR - LARIMAR THERAPEUTICS INC | 0.58% | $43.8M | -68.46% | -14.23% | |||
| ABOS - ACUMEN PHARMACEUTICALS INC | 0.48% | $36.1M | -59.00% | -8.05% | |||
| TRML - TOURMALINE BIO INC | New Purchase | 0.43% | $32.7M | +35.41% | +81.79% | ||
| THRD - THIRD HARMONIC BIO INC | New Purchase | 0.35% | $26.4M | -55.55% | +2.10% | ||
| SLDB - SOLID BIOSCIENCES INC | 0.32% | $24.6M | -50.12% | -43.08% | |||
| TSHA - TAYSHA GENE THERAPIES INC | 0.32% | $24.4M | +25.22% | -10.43% | |||
| TNYA - TENAYA THERAPEUTICS INC | New Purchase | 0.31% | $23.6M | -81.82% | -33.67% | ||
| VOR - VOR BIOPHARMA INC | 0.30% | $22.7M | -73.38% | +2.85% | |||
| AVTE - AEROVATE THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| BOLD - BOUNDLESS BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
| CCCC - C4 THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| CTKB - CYTEK BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| INBX - INHIBRX INC | Reduce 100% | 0.00% | $0.00 | ||||
| MDGL - MADRIGAL PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| HOWL - WEREWOLF THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||